Literature DB >> 2122210

Update: analysis of L-tryptophan for the etiology of eosinophilia-myalgia syndrome.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2122210

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


× No keyword cloud information.
  5 in total

1.  Identification of decomposition products of 1,1'-ethylidenebis [L-tryptophan], a compound associated with eosinophilia-myalgia syndrome.

Authors:  W J Driskell; D L Ashley; J Grainger; S R Sirimanne; E P Mazzola; S W Page; L L Needham; R H Hill
Journal:  Bull Environ Contam Toxicol       Date:  1992-05       Impact factor: 2.151

Review 2.  Tryptophan. Current status and future trends for oral administration.

Authors:  L D Kaufman; R M Philen
Journal:  Drug Saf       Date:  1993-02       Impact factor: 5.606

3.  Subchronic toxicity of 3-phenylamino alanine, an impurity in L-tryptophan reported to be associated with eosinophilia-myalgia syndrome.

Authors:  F Sato; Y Hagiwara; Y Kawase
Journal:  Arch Toxicol       Date:  1995       Impact factor: 5.153

4.  Contaminants in L-tryptophan associated with eosinophilia myalgia syndrome.

Authors:  R H Hill; S P Caudill; R M Philen; S L Bailey; W D Flanders; W J Driskell; M L Kamb; L L Needham; E J Sampson
Journal:  Arch Environ Contam Toxicol       Date:  1993-07       Impact factor: 2.804

5.  1,1'-Ethylidenebis(tryptophan) (Peak E) induces functional activation of human eosinophils and interleukin 5 production from T lymphocytes: association of eosinophilia-myalgia syndrome with a L-tryptophan contaminant.

Authors:  K A Yamaoka; N Miyasaka; G Inuo; I Saito; J P Kolb; K Fujita; S Kashiwazaki
Journal:  J Clin Immunol       Date:  1994-01       Impact factor: 8.317

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.